2022
DOI: 10.1093/jamia/ocac029
|View full text |Cite
|
Sign up to set email alerts
|

The technical landscape for patient-centered CDS: progress, gaps, and challenges

Abstract: Supporting healthcare decision-making that is patient-centered and evidence-based requires investments in the development of tools and techniques for dissemination of patient-centered outcomes research findings via methods such as clinical decision support (CDS). This article explores the technical landscape for patient-centered CDS (PC CDS) and the gaps in making PC CDS more shareable, standards-based, and publicly available, with the goal of improving patient care and clinical outcomes. This landscape assess… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 22 publications
(24 reference statements)
0
9
0
Order By: Relevance
“…These findings highlight a risk that real-time benefit tools, if used by clinicians but not discussed with patients, could drive prescribing decisions that are not patient-centered but rather reflect prescribers' assumptions about their patient's needs. 17 We found that nearly all (89.0%) respondents said they would be comfortable or neutral regarding being screened for their interest in a medication cost conversation before their physician's visit. Prior studies have shown that physicians infrequently initiate cost conversations [18][19][20][21] and are concerned that patients may be uncomfortable with discussing treatment costs.…”
Section: Discussionmentioning
confidence: 83%
See 1 more Smart Citation
“…These findings highlight a risk that real-time benefit tools, if used by clinicians but not discussed with patients, could drive prescribing decisions that are not patient-centered but rather reflect prescribers' assumptions about their patient's needs. 17 We found that nearly all (89.0%) respondents said they would be comfortable or neutral regarding being screened for their interest in a medication cost conversation before their physician's visit. Prior studies have shown that physicians infrequently initiate cost conversations [18][19][20][21] and are concerned that patients may be uncomfortable with discussing treatment costs.…”
Section: Discussionmentioning
confidence: 83%
“…Respondents described varied levels of distress if their physician used the real-time benefit tool but did not discuss prices with them, with about equal proportions saying they would not be upset as said they would be very upset. These findings highlight a risk that real-time benefit tools, if used by clinicians but not discussed with patients, could drive prescribing decisions that are not patient-centered but rather reflect prescribers’ assumptions about their patient’s needs …”
Section: Discussionmentioning
confidence: 99%
“…PGHD can also offer providers more accurate measurements and temporal insight into a particular disease, 6 enabling clinicians to use the data to guide discussions with patients and use clinic time more efficiently. 6 7…”
Section: Background and Significancementioning
confidence: 99%
“…First, integration with current EHRs and clinical workflows is limited, 6 which is a barrier to development of PC CDS centering on patients' individual needs. 7 Second, large volumes of automatically captured, high-frequency data can be time-consuming to view, and cognitively difficult to interpret, which contributes to clinician burnout. 8 Third, while clinical guidelines offer recommendations based on physiologic measurements obtained in outpatient clinic visits, 9 similar evidence-based interpretation of PGHD is lacking, hindering PGHD use in patient care.…”
Section: Background and Significancementioning
confidence: 99%
See 1 more Smart Citation